why choose us

300×250 Ad Slot

Research Article: Impact of ESPGHAN no-biopsy strategy on the outcome of celiac disease treatment in children

Date Published: 2025-03-20

Abstract:
Aim: The European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) allows a no-biopsy diagnostic of celiac disease under certain conditions. We assessed the impact of the diagnostic algorithm on the patient's long-term outcome by comparing the serology-based diagnosed patients to biopsy-proven ones.

No summary available.

300×250 Ad Slot